Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Lysosomal cysteine proteases regulate antigen presentation.

Honey K, Rudensky AY.

Nat Rev Immunol. 2003 Jun;3(6):472-82. Review.

PMID:
12776207
2.

Lysosomal cysteine proteases and antigen presentation.

Rudensky A, Beers C.

Ernst Schering Res Found Workshop. 2006;(56):81-95. Review.

PMID:
16329647
3.

The lysosomal cysteine proteases in MHC class II antigen presentation.

Hsing LC, Rudensky AY.

Immunol Rev. 2005 Oct;207:229-41. Review.

PMID:
16181340
4.

Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L.

Reinheckel T, Deussing J, Roth W, Peters C.

Biol Chem. 2001 May;382(5):735-41. Review.

PMID:
11517926
5.

Cysteine cathepsins in the immune response.

Zavasnik-Bergant T, Turk B.

Tissue Antigens. 2006 May;67(5):349-55. Review.

PMID:
16671941
6.

Proteases involved in MHC class II antigen presentation.

Villadangos JA, Bryant RA, Deussing J, Driessen C, Lennon-Duménil AM, Riese RJ, Roth W, Saftig P, Shi GP, Chapman HA, Peters C, Ploegh HL.

Immunol Rev. 1999 Dec;172:109-20. Review.

PMID:
10631941
7.

The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.

Nakagawa TY, Rudensky AY.

Immunol Rev. 1999 Dec;172:121-9. Review.

PMID:
10631942
8.

Cysteine proteases: destruction ability versus immunomodulation capacity in immune cells.

Zavasnik-Bergant T, Turk B.

Biol Chem. 2007 Nov;388(11):1141-9. Review.

PMID:
17976006
9.
10.

Cysteine protease cathepsin S as a key step in antigen presentation.

Liu W, Spero DM.

Drug News Perspect. 2004 Jul-Aug;17(6):357-63. Review.

PMID:
15334187
11.

Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.

Gelin C, Sloma I, Charron D, Mooney N.

J Leukoc Biol. 2009 Feb;85(2):215-24. doi: 10.1189/jlb.0308206. Epub 2008 Sep 22. Review.

PMID:
18809734
12.

CD1 and MHC II find different means to the same end.

Sullivan BA, Nagarajan NA, Kronenberg M.

Trends Immunol. 2005 May;26(5):282-8. Review.

PMID:
15866242
13.

The Third Way: Progress on pathways of antigen processing and presentation by CD1.

Lawton AP, Kronenberg M.

Immunol Cell Biol. 2004 Jun;82(3):295-306. Review.

14.

A closer look at proteolysis and MHC-class-II-restricted antigen presentation.

Lennon-Duménil AM, Bakker AH, Wolf-Bryant P, Ploegh HL, Lagaudrière-Gesbert C.

Curr Opin Immunol. 2002 Feb;14(1):15-21. Review.

PMID:
11790528
15.

The p41 fragment story.

Turk D, Guncar G, Turk V.

IUBMB Life. 1999 Jul;48(1):7-12. Review.

16.

Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.

Li P, Gregg JL, Wang N, Zhou D, O'Donnell P, Blum JS, Crotzer VL.

Immunol Rev. 2005 Oct;207:206-17. Review.

PMID:
16181338
17.

Lysosomal cysteine proteases: structure, function and inhibition of cathepsins.

Roberts R.

Drug News Perspect. 2005 Dec;18(10):605-14. Review.

PMID:
16491162
18.

Regulation of antitumour immunity by CD1d-restricted NKT cells.

Swann J, Crowe NY, Hayakawa Y, Godfrey DI, Smyth MJ.

Immunol Cell Biol. 2004 Jun;82(3):323-31. Review.

19.

CD1d ligands: the good, the bad, and the ugly.

Brutkiewicz RR.

J Immunol. 2006 Jul 15;177(2):769-75. Review.

20.

Endo-lysosomal proteases in antigen presentation.

van Kasteren SI, Overkleeft HS.

Curr Opin Chem Biol. 2014 Dec;23:8-15. doi: 10.1016/j.cbpa.2014.08.011. Epub 2014 Sep 15. Review.

PMID:
25213682

Supplemental Content

Support Center